Navigation Links
CeloNova First to Produce Super-Sized Embolic Microsphere
Date:10/30/2009

tumors and arteriovenous malformations. The 75, 1100, 1300, and 2800 micron sizes are not yet available in the US.

About CeloNova BioSciences: Headquartered in Newnan, Georgia, CeloNova develops novel medical devices that are enhanced by one of the Company's proprietary materials, Polyzene®-F, a lubricious, anti-thrombotic, anti-inflammatory, and bacterial-resistant surface treatment. The Company's current products include Embozene(TM) Color-Advanced Microspheres and the CATANIA(TM) Coronary Stent System with NanoThin Polyzene®-F. Both products are CE Marked. For more information, visit www.celonova.com.

    CONTACT:
    Teresa Wilson
    CeloNova BioSciences, Inc.
    +1 (678) 895-6486
    +1 (770) 502-0304
    twilson@celonova.com

SOURCE CeloNova BioSciences, Inc.


'/>"/>
SOURCE CeloNova BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
2. First biomarker discovered that predicts prostate cancer outcome
3. FDA Approves First Anti-Psychotic for Kids
4. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
5. First study examines newly-licensed RN work attitudes and intentions
6. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
9. High and mighty: first common height gene identified by researchers behind obesity gene finding
10. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
11. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Innovative medical apparel com...rence , San Clemente, Cal...ker of breakthrough medical apparel, today announc... display at Medica 2009, a leading international t...orf, Germany. Medelita inaugurates its men,s colle...
(Date:11/20/2009)..., Pioneering Neurologist Closer to Understandin... 20 Dr. Jeremy Schmahma...ol and neurologist at the Massachusetts General Ho...ted his laboratory,s research on the new field of ...INDlink Foundation. ,, Dr. Schmahmann is an awa...
(Date:11/20/2009)... Senators and Congressmen in Co...Over their Health Care Vote , ...enators and congressmen running for re-election ne...ical guru Charlie Cook, may come to regret voting ... bill, according to a breaking Zogby International...
(Date:11/20/2009)..., WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNe...s on a mission to redefine what it means to be "ha...al counselor with a specialty in family counseling... Forest University, Gladding says research shows t...s to sadness and even depression during the holida...
(Date:11/20/2009)... blood pressure readings in children with chronic ...even during doctor,s office visits increasing a c...to research from Johns Hopkins Children,s Center a...pears online in the Journal of American Society of...sure measurements obtained during regular doctor v...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2
...on leaders will,convene in Arlington, Virginia, Ma...s, practical applications, and strategies for the ... technology will be used to make the,meeting highl... being,developed under the direction of the progra...
...wn as stomach fluindicate the highly contagious, f... The Association for Professionals in Infection Co... to protect families against noroviruses. , Noro...etween 24 and 48 hours after exposure. Norovirus c...
...d track record in the analysis of genomic data gen...algorithms include optimized fast mapping strategi...e genome annotation in terms of transcriptome and ...aboration with customers, successfully analyzing N...
... close to 25% primarily driven by a ...N, N.J., Jan. 31 Novo Nordisk (NYSE:,NVO), a glob...l statement,for 2007., -- Sales in local currenc...voSeven(R) increased by 10% (4% in Danish kroner)....
...Out-Patient Treatments and Services, LOS ANGELES,...om the popular series Nip/Tuck, but don,t be foole... one of the country,s most notable,cosmetic surgeo... and,Conference. He will also be available for per...
...health, the largest and most common form of fat in...aken a back seat to "bad" LDL cholesterol and,"goo...,s changing as,researchers get a grip on how trigl... they slide above 200,milligrams per deciliter of ...
Other Medicine News:Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 3Health News:6 simple steps to protect against and stop the spread of noroviruses 2Health News:Novo Nordisk Increased Net Profit by 32% in 2007 2Health News:Dr. Gregory Buford and Top Plastic Surgeon Selected as a Keynote Speaker at Spa & Resort Expo LA Convention Center, February 23-25 2Health News:Tackling Triglycerides: 8 Ways to Solve a Big Fat Problem, From the Harvard Heart Letter 2
(Date:11/20/2009)... Cyberonics, Inc. (Nasdaq...t and Chief Executive Officer, and Greg Browne, Ch...nual Piper Jaffray Health Care Conference in New Y.... The conference session and webcast will be audi...per Jaffray will host a webcast of the presentatio...
(Date:11/20/2009)...ov. 20 Soligenix, Inc. (...y), formerly known as DOR BioPharma, Inc., a late-...it has formed a consortium to develop thermostable... acting vaccines. Soligenix received a $9.4 millio... Infectious Diseases (NIAID), a division of the Na...
(Date:11/19/2009)...ov. 19 In a series of ne..., Heska Corporation (Nasdaq: HSKA ) ("Heska" or t...w and improved website. The upgraded site is the ...rogramming to align the site with the company,s ne...go: http://www.newscom.com/cgi-bin/prnh/20000622...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3The decision about the incision 3A Is midline or transverse better for abdominal surgery 3F 50399 1The decision about the incision 3A Is midline or transverse better for abdominal surgery 3F 50399 2A thirst for blood sparks toxic algal blooms 9065 1A thirst for blood sparks toxic algal blooms 9065 2Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 50396 1Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 50396 2Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 50396 3Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 50396 4
...ndash; MediQuest Therapeutics,Inc., a specialty p...ies for inflammatory and infectious diseases, toda...se III study of Vascana,– a topical formulat...he study met its primary end point and demonstrate... Intent-to-Treat patient,population. Typically, a...
...amp; SHERBROOKE, Quebec--(BUSINESS,WIRE)--Jun 26, ...l,company developing small molecule drugs for the ...es, today announced positive,results for its novel... emptying in diabetic patients with gastroparesis....ted at the American,Diabetes Association,s 67th Sc...
Other Medicine Technology:MediQuest Concludes Confirmatory Phase III Study of Raynaud’s,Therapy 2Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis 2Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis 3
Double Maddox
Maddox Rod, long handle
Snellen 10' Eye Test Chart
Ultrasonic Pachymeter UP-1000
Medicine Products: